アルツハイマー病を予防する
1Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. dselkoe@rics.bwh.harvard.edu
Science (New York, N.Y.)
|September 22, 2012
まとめ
アルツハイマー病の有効な治療法は未だに捉え難いままです. 将来の成功は,検証されたバイオマーカーを用いた早期の介入と,研究への投資の増加に依存する.
科学分野:
- 神経科学は神経科学である.
- ゲロントロジーはゲロントロジーの学科です.
- クリニカル・メディシン 臨床医学
背景:
- アルツハイマー病 (AD) 研究は,決定的な治療法なしで30年間続いた.
- 最近の臨床試験は,軽度から中度まで進行する前,早期の介入が必要であることを示しています.
研究 の 目的:
- 早期のAD介入の必要性を強調する.
- 二次予防試験におけるバイオマーカーの役割を強調する.
- 投資を増やし,試験設計を洗練する必要性を強調する.
主な方法:
- 最近のアルツハイマー病の臨床試験結果の分析.
- ADの症状前のバイオマーカーを検証する進捗状況のレビュー.
- 病気の自然な進行と治療的反応についての議論.
主要な成果:
- 症状前のバイオマーカーの検証は,二次予防試験を可能にします.
- 過去の治験の分析は,病気の自然史についての洞察を提供します.
- 現在のアプローチでは,まだ効果的な治療法が得られていません.
結論:
- アルツハイマー病を早期に治療することは,潜在的な治療の成功にとって極めて重要です.
- さらなる投資と細心の注意を払った試験設計は,AD研究を進めるために不可欠です.
- バイオマーカーの開発は,効果的な二次予防戦略を可能にするための鍵です.
関連する概念動画
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.